CRNX CapEx to Revenue

Crinetics Pharmaceuticals Inc · CapEx to Revenue

CRNX logo

CRNX CapEx to Revenue

Current (TTM)6.31%
CRNX CapEx/Revenue (32.26% → 6.31%)
High-resolution chart · PNG

CRNX capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
74.8701%
369.9711%
116.8203%
34.9588%
40.4453%
261.9718%
41.2406%
43.6161%
14.8655%
32.2581%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.